Mission Produce Q3 revenue jumps 26%; Calavo synergy target raised to >$30M but integration risks remain

What happened

Mission Produce reported fiscal Q3 2026 revenue of $450 million, up 26% year-over-year, reflecting the first full quarter including Calavo Growers and continued volume growth in avocados. Management increased its annualized Calavo synergy estimate to more than $30 million from the prior $25 million, signaling faster-than-expected integration cost savings. The company reaffirmed its second-half fiscal 2026 guidance, suggesting no major negative surprises. However, the revenue growth is partly inorganic due to the acquisition, and the overall margin profile will depend on successful integration and tariff management. Investors should scrutinize the 10-Q for details on organic growth, EBITDA margins, and working capital as the company absorbs Calavo.

Implication

Longer term, if Mission can sustain mid-single-digit organic volume growth and deliver the raised synergies, pro forma EBITDA should approach or exceed $180 million, supporting a valuation closer to $18. However, the company still faces structural risks from customer concentration, tariff exposure, and high capex that will limit free cash flow generation until integration is complete. The increased synergy target is encouraging but must be realized without service disruption to large retail customers. Investors should monitor quarterly margin trends and any signs of tariff cost pass-through failure. A pullback toward $11–12 would provide a more attractive entry, while a rise above $16 without evidence of durable margin expansion would warrant trimming.

Thesis delta

The core thesis is unchanged: Mission remains a scaled avocado platform with moderate valuation and meaningful integration upside from Calavo. The raised synergy target modestly improves the bull case, but does not by itself justify re-rating the stock above the master report's $16 trim level. We maintain a WAIT rating and would only turn constructive on evidence of sustained EBITDA margin above 8% and successful synergy realization over the next two quarters.